SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-24-026033
Filing Date
2024-05-31
Accepted
2024-05-31 16:06:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 contexttherapeuticsfinalpr.htm 424B3 196193
2 contextlogoa.jpg GRAPHIC 47702
  Complete submission text file 0001628280-24-026033.txt   258928
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-279693 | Film No.: 241009682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)